Saturday 17 October 2026
Export MLTX’s income statement to Excel — free account
MoonLake Immunotherapeutics
MLTX Healthcare Biotechnology
In the quarter to June 2026, EPS grew 3.45%, free cash flow fell 1.89% and total debt rose 35.6%, each against the same quarter a year earlier.
9.55
0.71
−6.92%
Follow MLTX
A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.
| Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 | Dec '20 | |
|---|---|---|---|---|---|---|
Cash and Short Term Investments |
393.97 | 448.03 | 511.01 | 72.11 | 8.04 | 1.34 |
Receivables |
4.87 | 2.84 | 1.06 | 0.22 | 0.15 | — |
Total current assets |
421.69 | 474.29 | 514.17 | 76.51 | 9.64 | 1.62 |
Property, Plant, Equpment (Net) |
0.58 | 0.72 | 0.32 | 0.05 | 0.05 | — |
Long-Term Investments |
— | — | — | — | — | 115.01 |
Long-term assets (Other) |
0.60 | — | 8.42 | — | — | — |
Total non-current assets |
2.74 | 3.64 | 12.37 | 0.33 | 0.05 | 115.01 |
Total Assets |
424.43 | 477.93 | 526.54 | 76.84 | 9.68 | 116.63 |
Notes Payable |
— | — | — | — | — | 0.06 |
Accounts Payable |
29.55 | 8.99 | 1.84 | 0.26 | 1.57 | 0.07 |
Accrued Expenses |
14.69 | 12.10 | 6.93 | 7.26 | 4.52 | 0.07 |
Current Part of Debt |
— | — | — | — | 15.00 | 0.06 |
Total current liabilities |
45.48 | 22.46 | 9.97 | 7.67 | 21.09 | 0.13 |
Long Term Debt (Total) |
74.10 | — | — | 0.13 | — | — |
Non-current Revenue (Deferred) |
— | — | — | — | — | 4.03 |
Pension and Post-Retirement Liabilities |
0.00 | 0.62 | 0.58 | 0.28 | 0.24 | — |
Non-current Liabilities (Other) |
— | — | — | — | — | 115.00 |
Total non-current liabilities |
74.47 | 2.08 | 3.08 | 0.41 | 0.24 | 119.03 |
Total liabilities |
119.95 | 24.54 | 13.05 | 8.08 | 21.33 | 119.15 |
Additional Paid In Capital |
766.78 | 677.42 | 609.97 | 129.19 | 42.06 | — |
Preferred Stock (Total) |
— | — | — | — | 0.07 | — |
Common Stock (Net) |
0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.00 |
Retained Earnings |
(462.91) | (235.59) | (116.66) | (80.65) | (53.64) | (2.52) |
Treasury Stock |
— | — | — | — | 0.01 | — |
Common Equity (Total) |
304.48 | 453.39 | 513.49 | 68.77 | (11.72) | (2.52) |
Shareholders Equity (Total) |
304.48 | 453.39 | 513.49 | 68.77 | (11.64) | (2.52) |
Shareholders Equity and Liabilities (Total) |
424.43 | 477.93 | 526.54 | 76.84 | 9.68 | 116.63 |
Shares (Common) |
71.37 | 63.92 | 62.97 | 52.70 | 10.22 | 3.31 |
Shares (Preferred) |
— | — | — | — | 22.88 | — |
Shareholders Equity (Tangible) |
304.48 | 453.39 | 513.49 | 68.77 | (11.64) | (2.52) |
Net Debt |
(319.87) | (448.03) | (511.01) | (71.99) | 6.96 | (1.28) |
Total Debt |
74.10 | — | — | 0.13 | 15.00 | 0.06 |
In millions of $ except per-share values · columns are period end dates